Prudent Man Advisors LLC Has $455,000 Stock Position in Albemarle Corporation $ALB

Prudent Man Advisors LLC lifted its stake in Albemarle Corporation (NYSE:ALB) by 41.1% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 7,255 shares of the specialty chemicals company’s stock after purchasing an additional 2,112 shares during the quarter. Prudent Man Advisors LLC’s holdings in Albemarle were worth $455,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the business. Moran Wealth Management LLC boosted its position in Albemarle by 1.6% during the 2nd quarter. Moran Wealth Management LLC now owns 9,482 shares of the specialty chemicals company’s stock worth $594,000 after acquiring an additional 148 shares during the period. DekaBank Deutsche Girozentrale boosted its position in Albemarle by 0.7% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 22,798 shares of the specialty chemicals company’s stock worth $1,496,000 after acquiring an additional 148 shares during the period. National Pension Service boosted its position in Albemarle by 74.5% during the 1st quarter. National Pension Service now owns 452 shares of the specialty chemicals company’s stock worth $33,000 after acquiring an additional 193 shares during the period. Teachers Retirement System of The State of Kentucky boosted its position in Albemarle by 2.6% during the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 9,028 shares of the specialty chemicals company’s stock worth $650,000 after acquiring an additional 228 shares during the period. Finally, OneDigital Investment Advisors LLC boosted its position in Albemarle by 6.7% during the 1st quarter. OneDigital Investment Advisors LLC now owns 3,782 shares of the specialty chemicals company’s stock worth $272,000 after acquiring an additional 239 shares during the period. 92.87% of the stock is currently owned by institutional investors and hedge funds.

Albemarle Stock Up 8.5%

Shares of ALB stock opened at $105.65 on Friday. The stock’s 50 day simple moving average is $85.52 and its 200 day simple moving average is $71.46. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.47 and a current ratio of 2.31. Albemarle Corporation has a twelve month low of $49.43 and a twelve month high of $113.91. The company has a market capitalization of $12.43 billion, a price-to-earnings ratio of -11.34 and a beta of 1.65.

Albemarle (NYSE:ALB) last issued its quarterly earnings data on Wednesday, July 30th. The specialty chemicals company reported $0.11 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.83) by $0.94. Albemarle had a negative return on equity of 1.87% and a negative net margin of 18.61%.The business had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.23 billion. During the same period last year, the business earned $0.04 EPS. The firm’s revenue was down 7.0% compared to the same quarter last year. Albemarle has set its FY 2025 guidance at EPS. As a group, research analysts predict that Albemarle Corporation will post -0.04 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages have commented on ALB. HSBC raised their price objective on Albemarle from $60.00 to $75.00 and gave the stock a “hold” rating in a research report on Monday, September 22nd. UBS Group decreased their price objective on Albemarle from $89.00 to $85.00 and set a “neutral” rating for the company in a research report on Monday, October 6th. Argus lifted their price target on Albemarle from $90.00 to $120.00 in a report on Tuesday, October 14th. Jefferies Financial Group lifted their price target on Albemarle from $90.00 to $105.00 and gave the company a “buy” rating in a report on Monday, October 6th. Finally, Baird R W lowered Albemarle from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 29th. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating, fourteen have assigned a Hold rating and five have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $95.33.

Albemarle Company Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.